Dr. Faiyaz Notta
Dr. Faiyaz Notta is an Associate Researcher at OICR and Principal Investigator at the Princess Margaret Cancer Centre. He employs genomic, cell biology and single-cell approaches to decipher new molecular targets that are needed to treat pancreatic cancer.
Notta has made important contributions to our understanding of the genomic evolution of pancreatic cancers alongside Dr. Steven Gallinger as part of OICR’s PanCuRx Translational Research Initiative.
- Associate, OICR;
- Scientist, Princess Margaret Cancer Centre.
- Pancreatic cancer;
- Cancer stem cells;
- Cancer genomics;
- Cell biology.
Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, Chadwick D, Hafezi-Bakhtiari S, Dick JE, Heisler L, Hollingsworth MA, Ibrahimov E, Jang GH, Johns J, Jorgensen LG, Law C, Ludkovski O, Lungu I, Ng K, Pasternack D, Petersen GM, Shlush LI, Timms L, Tsao MS, Wilson JM, Yung CK, Zogopoulos G, Bartlett JM, Alexandrov LB, Real FX, Cleary SP, Roehrl MH, McPherson JD, Stein LD, Hudson TJ, Campbell PJ, Gallinger S.
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE.
Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment.
Milyavsky M, Gan OI, Trottier M, Komosa M, Tabach O, Notta F, Lechman E, Hermans KG, Eppert K, Konovalova Z, Ornatsky O, Domany E, Meyn MS, Dick JE.
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.
Cell Stem Cell. 2010;7(2):186-97.
See Dr. Notta’s recent publications on PubMed.
- PhD, University of Toronto.
Opportunities to collaborate
To collaborate with Dr. Notta, please contact him directly.
Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.